Skip to main content

Advertisement

Log in

ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Funding

This research did not receive financial support from any sources.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge Humberto Rodriguez-Quintero MD.

Ethics declarations

Disclosures

Brendon Stiles: Medtronic, AstraZeneca, Genentech, Pfizer, Arcus Biosciences, Bristol Myers Squib, BMS Foundation, Gala Therapeutics, Merck, and the Lung Cancer Research Foundation. Jorge Humberto Rodriguez-Quintero, Mohamed K. Kamel, Rajika Jindani, Mostafa Elbahrawy, Marc Vimolratana, and Neel Chudgar have no conflicts of interest to disclose.

Ethical approval

This research was performed in accordance with the 1964 Helsinki Declaration and its later amendments and was approved by an Institutional Review Board. This work has not been published elsewhere.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodriguez-Quintero, J.H., Kamel, M.K., Jindani, R. et al. ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma. Ann Surg Oncol 31, 1595–1596 (2024). https://doi.org/10.1245/s10434-023-14675-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14675-x

Navigation